Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure
Tóm tắt
The response of parathyroid cells to serum calcium is regulated by a calcium-sensing receptor protein (CaR). In patients with chronic renal failure, hypocalcemia contributes to the parathyroid hyperplasia and increased parathyroid hormone secretion characteristic of secondary hyperparathyroidism (sHPT). However, patients with uremia also display reduced sensitivity to extracellular calcium; this seems to be owing to an alteration of the receptor mechanism. This study examined calcium receptor expression in the parathyroid tissue of patients with sHPT, using immunohistochemical technicques and comparison with normal tissue and parathyroid glands of patients with primary hyperparathyroidism. In all the glands studied, immunostaining was more intense in chief cells than in oxyphilic, transitional, and clear cells. The parathyroid glands of patients with sHPT displayed significantly reduced expression of CaR with respect to morphologically normal ones; a very similar reduction is reported in adenomas. Furthermore, in glands displaying multinodular hyperplasia, expression was less marked in nodule-forming cells than in internodular areas. The decreased expression of calcium receptors in the parathyroid tissue of uremic patients was thought to be owing to the different cell populations present; these parathyroid glands contained predominantly transitional, oxyphilic, and clear cells, which normally express fewer receptors than chief cells, which are more abundant in normal glands.
Tài liệu tham khảo
Felsenfeld AJ, Llach F. Parathyroid gland function in renal failure. Kidney Int 43:771–789, 1993.
Silver J, Moallem E, Epstein E, Kilau R, Naveh-Maney T. New aspects in the control of parathyroid hormone secretion. Curr Opin Nephrol 3:379–385, 1994.
Hory B, Drücke TB. The parathyroid-bone axis in uremia: new insights into old questions. Curr Opin Nephrol 6:40–48, 1997.
Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366:575–580, 1993.
Russell J, Lettieri D, Sherwood LM. Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for preproparathyroid hormone in isolated bovine parathyroid cells. J Clin Invest 72:1851–1855. 1983.
Brookman JJ, Farrow SM, Nicholson L, et al. Regulation by calcium of parathyroid hormone mRNA in cultured parathyroid tissue. J Bone Miner Res 1:529–537, 1986.
Wallfelt CH, Larsson R, Gylfe E, et al. Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implications for parathyroid autotransplantation. World J Surg 12:431–438, 1988.
Tominaga Y, Sato K, Tanaka Y, et al. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 44(Suppl 1):S42-S47, 1995.
D'amour P, Palady J, Bahsali G., et al. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab 74:525–532, 1992.
Szabo A, Merke J, Beier E, et al. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35:1045–1056, 1989.
Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats: the effects of calcium, phosphate and vitamin D. J Clin Invest 96:1786–1793, 1995.
Brown EM, Wilkson RE, Eastman RC, et al. Abnormal regulation of parathyroid hormone release of calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 54:172–179, 1982.
Brown EM, Broadus AE, Brennan MF, et al. Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism. J Clin Endocrinol Metab 48:604–610, 1979.
Pollak MR, Brown EM, Chou YHW, et al. Mutations in the human extracellular Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303, 1993.
Khosla S, Ebeling PR, Firek AF, et al. Calcium infusion suggest a “set point” abnormality of parathyroid gland function in familiar benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76:715–720, 1993.
Marx SJ, Lasker R, Brown E, et al. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J Clin Endocrinol Metab 62:445–448, 1986.
Hosokawa Y, Pollak MR, Brown EM, Arnold A. The extracellular Ca2+-sensing receptor gene in human parathyroid adenomas. J Clin Endocrinol Metab 80:3107–3110, 1995.
Racke FK, Nemeth EF. Cytosolic calcium homeostasis in bovine parathyroid cells and its modulation by protein kinase C. J Physiol 468:141–162, 1993.
Racke FK, Nemeth EF. Protein kinase C modulates hormone secretion regulated by extracellular polications in bovine parathyroid cells. J Physiol 468:163–176, 1993.
Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with parathyroidism. Kidney Int 51:328–336, 1997.
Kifor O, Moore FE, Wang P, et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 80:1598–1606, 1996.
Yano S, Sugimoto T, Tsukamoto T, et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathy roidism. Kidney Int 58:1980–1986, 2000.
Yamaguchi S, Yachiku S, Morikawa M. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Endocrinol Metab 82:2681–2688, 1997.